TrialMolecular medicine reports2016

Whole-genome re-sequencing for the identification of high contribution susceptibility gene variants in patients with type 2 diabetes.

Xiaojuan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.